Trial Profile
Impact of treatment with Dapagliflozin (SGLT2 inhibitor) in metabolic control and glycemic pattern in type 1 diabetic patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 17 Nov 2015 New trial record